As of November 2026 Retension Pharmaceuticals has a market cap of ยฃ75.21 Million. This makes Retension Pharmaceuticals the world's 9760th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 10th, 2026 the market cap of Retension Pharmaceuticals was reported to be: